are co-founders of Ousia Pharma, a biotech company developing therapeutics for treatment of obesity
Younger adults appear more engaged with emerging conversations around GLP-1 treatments and weight loss innovation, while older adults remain significantly less aware of the shift towards tablets
Pharmacodynamic endpoints were the changes from baseline in exploratory biomarkers related to liver function and fatty liver disease (plasma levels of cytokeratin 18 and Pro-C3 and enhanced liver fibrosis [ELF] score), glucose metabolism (adiponectin and fasting insulin and C-peptide levels) and target receptor engagement (amino acid and glucagon levels)
When I started taking a GLP-1 medication in October, I knew it would probably change a few thingsour weekly dinner plan, how my pants fit, my relationship to alcohol (initial research shows low-dose GLP-1 drug patients drink less of it)
This makes it an important option for people with type 2 diabetes, who are at a higher risk for heart disease
But if you make some changes in your diet you can take advantage of this opportunity that your own body offers to release GLP-1 after you eat a meal